Imperial College London

ProfessorGrahamCooke

Faculty of MedicineDepartment of Infectious Disease

Vice Dean (Research); Professor of Infectious Diseases
 
 
 
//

Contact

 

g.cooke

 
 
//

Location

 

Infectious Diseases SectionMedical SchoolSt Mary's Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Lee:2022:10.1186/s13063-022-06495-3,
author = {Lee, IR and Tong, SYC and Davis, JS and Paterson, DL and Syed-Omar, SF and Peck, KR and Chung, DR and Cooke, GS and Libau, EA and Rahman, S-NBA and Gandhi, MP and Shi, L and Zheng, S and Chaung, J and Tan, SY and Kalimuddin, S and Archuleta, S and Lye, DC},
doi = {10.1186/s13063-022-06495-3},
journal = {TRIALS},
title = {Early oral stepdown antibiotic therapy versus continuing intravenous therapy for uncomplicated Gram-negative bacteraemia (the INVEST trial): study protocol for a multicentre, randomised controlled, open-label, phase III, non-inferiority trial},
url = {http://dx.doi.org/10.1186/s13063-022-06495-3},
volume = {23},
year = {2022}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AU - Lee,IR
AU - Tong,SYC
AU - Davis,JS
AU - Paterson,DL
AU - Syed-Omar,SF
AU - Peck,KR
AU - Chung,DR
AU - Cooke,GS
AU - Libau,EA
AU - Rahman,S-NBA
AU - Gandhi,MP
AU - Shi,L
AU - Zheng,S
AU - Chaung,J
AU - Tan,SY
AU - Kalimuddin,S
AU - Archuleta,S
AU - Lye,DC
DO - 10.1186/s13063-022-06495-3
PY - 2022///
TI - Early oral stepdown antibiotic therapy versus continuing intravenous therapy for uncomplicated Gram-negative bacteraemia (the INVEST trial): study protocol for a multicentre, randomised controlled, open-label, phase III, non-inferiority trial
T2 - TRIALS
UR - http://dx.doi.org/10.1186/s13063-022-06495-3
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000827750400007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL - 23
ER -